Paul Rhodes

Principal investigator, leads Specific Diagnostics, Inc..

MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$10.9MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20172022
AwardsPatents
Federal awards as principal investigator

9 awards · $10.9M

DateAgencyAwardAmountCompany
Apr 29, 2022NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing
$998KSpecific Diagnostics, Inc.
May 17, 2021NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing
$977KSpecific Diagnostics, Inc.
May 10, 2020NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing
$3.0MSpecific Diagnostics, Inc.
Jan 18, 2019NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing.
$996KSpecific Diagnostics, Inc.
Jan 17, 2019NIHSBIR Phase II
Combining faster detection with ID: a new paradigm for mycobacterial culture
$984KSpecific Diagnostics, Inc.
Jan 30, 2018NIHSBIR Phase II
Combining faster detection with ID: a new paradigm for mycobacterial culture
$1.0MSpecific Diagnostics, Inc.
Jan 30, 2018NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing.
$995KSpecific Diagnostics, Inc.
Feb 7, 2017NIHSBIR Phase II
Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing.
$998KSpecific Diagnostics, Inc.
Jan 26, 2017NIHSBIR Phase II
Combining faster detection with ID: a new paradigm for mycobacterial culture
$1.0MSpecific Diagnostics, Inc.
Among 4,795 researchers in Medtech

Peer ranks

Federal funding#63
Awards as PI#166
Patents#505
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.